ASH 2021
Pirtobrutinib, a non-covalent Bruton’s tyrosine kinase (BTK) inhibitor, showed promising efficacy in patients with ...
A fixed-duration combination of the first-generation Bruton tyrosine kinase (BTK) inhibitor ibrutinib and the ...
Second-line therapy comprising standard rituximab plus bendamustine and bortezomib was effective and well-tolerated as ...
A study sought to assess response rates, dose modifications, and frequency of ocular adverse events in patients ...
A phase II study presented at the 2021 Annual Meeting & Exposition of the American Society of Hematology, reported ...
The all-oral, once-daily, fixed-duration combination of ibrutinib and venetoclax demonstrated superior undetectable MRD ...
In the iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) study, researchers explored whether ...
These results were presented at the 2021 American Society of Hematology Annual Meeting.
Researchers developed a virtual frailty assessment for older adults with hematologic malignancies and found no evidence ...
Nearly half of new diagnosed of multiple myeloma (MM) and non-Hodgkin lymphoma (NHL) are in patients over 75 years old.
Black patients with multiple myeloma (MM) had a longer time between diagnosis and initiation of daratumumab compared ...
Black patients with multiple myeloma (MM) were less likely to undergo a complete initial diagnostic evaluation for their ...
Socioeconomic status (SES) accounted for disparities in survival time between Hispanic and non-Hispanic White patients ...
An analysis of data from the CoMMpass trial revealed no obvious differences in significant measures of genomic variation ...
Enrollment of ethnic minorities into academic clinical trials of multiple myeloma (MM) in the United Kingdom was below ...
A study of individuals with multiple myeloma (MM) revealed significant racial disparities in the prevalence of obesity ...
Ahead of the 2021 American Society of Hematology (ASH) Annual Meeting & Exposition, the organization highlighted ...
Advertisement
Advertisement